Startseite
Login
English
Erweiterte Suche
Durchblättern nach ...
Publikationen im Überblick
Ansprechpartner
Hilfe
Verlagsversion
Forschungsdaten
DOI
PMC
 |
Open Access Hybrid |
|
möglich sobald bei der ZB eingereicht worden ist.
Plasma infrared molecular fingerprinting stratifies residual risk in coronary artery disease and reflects clonal haematopoiesis-associated biology.
Eur. Heart J.:ehag587 (2026)
Verlagsversion
Forschungsdaten
DOI
PMC
Background and Aims Residual cardiovascular risk remains substantial in patients with coronary artery disease (CAD) despite optimal secondary prevention. Clonal haematopoiesis of indeterminate potential (CHIP) contributes causally to this risk but requires sequencing for detection. Plasma infrared molecular fingerprinting (IMF), a spectroscopy-based assay, was evaluated as a sequencing-free tool for residual risk stratification and CHIP-aligned phenotyping. Methods The discovery cohort included 1341 patients with angiographically confirmed CAD (mean age 73 years, 76% male) followed for up to 10.7 years. Plasma IMF spectra, comprehensive clinical data, and targeted sequencing of 13 CHIP driver genes were measured. Penalized Cox models using IMF features were benchmarked against the guideline-recommended SMART2 score. Model performance was assessed by discrimination, reclassification, calibration, and decision curve analyses. External validation was performed in three independent cohorts (PRECAD2, 474 individuals; KORA, 3044 individuals; Lasers4Life, 2123 individuals). Results IMF+Age demonstrated superior mortality discrimination over SMART2 (C-index 0.79 vs 0.74, P < .01) and significant reclassification improvement. Decision curves showed greater net benefit across clinical thresholds. IMF-derived risk strata showed clear separation of Kaplan-Meier survival curves (log-rank P < .001), with mortality increasing from 3% (low-risk) to 27% (high-risk). Higher-risk strata were enriched for CHIP carriers, particularly spliceosome mutations. External validation reproduced expected risk patterns and comorbidity associations. Conclusions Plasma IMF provides rapid, low-cost, sequencing-free assessment of residual mortality risk in CAD, outperforming guideline-based scores while reflecting CHIP-associated biology. IMF offers a scalable phenotypic platform for precision secondary prevention and biology-guided trial design.
Altmetric
Weitere Metriken?
Zusatzinfos bearbeiten
[➜Einloggen]
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Schlagwörter
Clonal haematopoiesis; Coronary artery disease; Infrared molecular fingerprinting; Spectroscopic profiling; Risk stratification; Precision cardiovascular prevention; Atherosclerosis; Curve
ISSN (print) / ISBN
0195-668X
e-ISSN
1522-9645
Zeitschrift
European Heart Journal
Quellenangaben
Artikelnummer: ehag587
Verlag
Oxford University Press
Verlagsort
Great Clarendon St, Oxford Ox2 6dp, England
Begutachtungsstatus
Peer reviewed
Institut(e)
Institute of Epidemiology (EPI)
Förderungen
DZG Innovation fund
AMP
FNIH
Deutsches Herzzentrum Mnchen and Munich School of Robotics and Machine Learning
Bavarian State Ministry of Health and Care
Joint Research Center
Swedish Research Council
National Institutes of Health
German Federal Ministry of Education and Research
LMU Munich Centre for Advanced Laser Applications
Fondation Leducq
Bavarian State Ministry of Science and the Arts
German Heart Foundation
CMD
Swedish Heart Lung Foundation
AMP
FNIH
Deutsches Herzzentrum Mnchen and Munich School of Robotics and Machine Learning
Bavarian State Ministry of Health and Care
Joint Research Center
Swedish Research Council
National Institutes of Health
German Federal Ministry of Education and Research
LMU Munich Centre for Advanced Laser Applications
Fondation Leducq
Bavarian State Ministry of Science and the Arts
German Heart Foundation
CMD
Swedish Heart Lung Foundation